Search all trials

Find therapies in clinical trials near you – page 90

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hormone receptor positive breast cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Antipsychotics

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Efinopegdutide

Contact Research Centre

Small cell lung cancer

Not recruiting

Registered drug

Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Macular oedema+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Follicle centre lymphoma follicular grade I, II - III

Not recruiting

Registered drugNo placebo

Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Diffuse large B-cell lymphoma refractory+1

Not recruiting

Registered drugNo placebo

Study on ALLO-647 and ALLO-501A for Adults with Relapsed or Refractory Large B-Cell Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Allo-501A

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Renal cell carcinoma stage IV+1

Not recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Glomerulonephritis membranoproliferative+1

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pegcetacoplan

Contact Research Centre

Status epilepticus

Not recruiting

Investigational

Study on Ganaxolone for Patients with Refractory Status Epilepticus

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Ganaxolone

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Austria

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Find therapies in clinical trials near you – page 90

1 110 trials match your criteria

Hormone receptor positive breast cancer+1

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Metabolic dysfunction-associated steatohepatitis+1

Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

Small cell lung cancer

Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Macular oedema+1

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Follicle centre lymphoma follicular grade I, II - III

Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

Diffuse large B-cell lymphoma refractory+1

Study on ALLO-647 and ALLO-501A for Adults with Relapsed or Refractory Large B-Cell Lymphoma

Diffuse large B-cell lymphoma

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Renal cell carcinoma stage IV+1

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Glomerulonephritis membranoproliferative+1

Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Status epilepticus

Study on Ganaxolone for Patients with Refractory Status Epilepticus

Non-small cell lung cancer

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.